Report: FDA Announces Emergency Authorization of COVID-19 Plasma Treatment

Report: FDA Announces Emergency Authorization of COVID-19 Plasma Treatment

The U.S. Food and Drug Administration(FDA) has reportedly authorized the use of blood plasma from patients who have recovered from COVID-19 as a treatment for the illness.

According to Reuters, the FDA said on Saturday that early evidence suggests blood plasma can decrease mortality and improve the health of patients when administered in the first three days of their hospitalization.

See Also:   COVID-19 ; Even if 2nd wave happens, it won’t be like the first

The FDA reportedly said that it determined the safety of the product in an analysis of 20-thousand patients who received the treatment, adding that 70-thousand patients have been treated using blood plasma so far.

See Also:   South Korea adopts alert system on crowded beaches to curb virus spread

Reuters said the so-called “emergency use authorization” by the FDA came on the eve of the Republican National Convention, where Trump will be nominated to run for re-election.


About the author

She is an operating manager of HaB Korea. Love Korea, Love travel :) HaB it your way!
Subscribe to Magazine HaB Korea via Email

Enter your email address to subscribe to our online Magazine HaB Korea and receive updates on the latest articles, events and special offers!

Thank you for subscribing. Please check your email and confirm your subscription.

Something went wrong.

Send this to a friend